Company intelligence / Profile preview

Sharper Sense

New York City, NY, USAsharpersense.com ↗

Ownership: Private
Development stage: Other

Overview

Sharper Sense has demonstrated enhanced sensory performance in preclinical animal models. The company is preparing to conduct pilot clinical studies to evaluate efficacy in humans, particularly targeting speech comprehension and broader sensory improvements. Early applications are being tested with athletes, older adults, and individuals with neurological or sensory impairments.

Therapeutic areas: NeurologyOther
Modalities: DeviceNon-pharmacological therapyNeuromodulation device (wearable patch)
Industry: Assistive Medical Devices

Partnerships

Comcast NBCUniversal SportsTech AcceleratorNASCARUS Ski & Snowboard AssociationCornell Tech Runway Startups programColumbia University Neural Engineering Lab

Beyond the preview

Go deeper on Sharper Sense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sharper Sense.

Explore the full profile